TipRanks
Go Ultimate55% OFF

Vaxcyte (PCVX) Income Statement

Vaxcyte Income Statement

Last quarter (Q2 2026), Vaxcyte's total revenue was $0.00. In Q2, Vaxcyte's net income was $-284.30M. See Vaxcyte’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 923.67M$ 569.55M$ 468.04M$ 232.26M$ 103.67M
Depreciation and Amortization$ 24.86M$ 15.85M$ 10.17M$ 9.45M$ 3.46M
$ -741.77M$ -448.08M$ -392.10M$ -214.03M$ -96.61M
$ -923.67M$ -569.55M$ -468.04M$ -232.26M$ -103.67M
$ 157.05M$ 105.62M$ 65.78M$ 8.77M$ 3.59M
$ -766.63M$ -463.93M$ -402.27M$ -223.49M$ -100.08M
$ -766.63M$ -463.93M$ -402.27M$ -223.49M$ -100.08M
Per Share Metrics
Basic EPS$ -5.63$ -3.80$ -4.14$ -3.44$ -1.93
Diluted EPS$ -5.63$ -3.80$ -4.14$ -3.44$ -1.93
Weighted Average Shares Outstanding136.09M122.00M97.16M64.88M51.92M
Weighted Average Shares Outstanding (Diluted)136.09M122.00M97.16M64.88M51.92M

Currency in USD

Vaxcyte Earnings and Revenue History

-900M-600M-300M00 %0.4 %0.8 %1.2 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin